21 results match your criteria: "CardioVid Clinic[Affiliation]"
Am J Cardiol
February 2025
Cardiovid Clinic, Pontificia Bolivariana, University of Antioquia, Medellin, Colombia.
ESC Heart Fail
October 2024
Pontificia Bolivariana University - Antioquia's University, Medellín, Colombia.
Heliyon
August 2024
School of Health Sciences, Pontifical Bolivarian University, Medellín, Colombia.
Background: Bacteremia represents high rates of morbidity and mortality, especially in developing countries, highlighting the need for a diagnostic method that allows prompt and appropriate patient treatment. This study compared microbiological performance and adherence of two blood culture protocols for the diagnosis of bacteremia.
Methods: Quasi-experimental study conducted between June 2022 and February 2023.
Curr Probl Cardiol
December 2024
Heart Failure Department and Clinical Investigation Center Inserm1407, Louis Pradel Cardiovascular Hospital, Hospices Civils de Lyon, Claude Bernard University, Lyon, France.
Eur J Heart Fail
August 2024
Hôpital Cardiovasculaire Louis Pradel Hospices Civils de Lyon, Heart Failure Department Clinical Investigation Center Inserm 1407 CarMeN Inserm 1060, University Claude Bernard Lyon, Bron, France.
Microorganisms
March 2024
Faculty of Medicine, School of Health Sciences, Pontifical Bolivarian University, Medellín 050031, Colombia.
Introduction: Increased antimicrobial use during the COVID-19 pandemic has raised concerns about the spread of resistant bacteria. This study analyzed the frequency of device-associated infections (DAI) caused by resistant bacteria, the predictors of these infections, and 30-day all-cause mortality in patients with and without COVID-19.
Methods: A retrospective cohort study was conducted on DAI patients admitted to the ICU (intensive care unit) in 20 hospitals in Medellin, Colombia (2020-2021).
Open Heart
April 2024
Pontificia Bolivariana, University of Antioquia, Cardiovid Clinic, Medelin, Colombia.
Curr Probl Cardiol
February 2024
CardioVID Clinic, Medellín, Colombia; Department of Internal Medicine, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia.
Introduction: The evidence supporting pharmacological heart failure treatment relies on randomized clinical trials with stringent inclusion and exclusion criteria.
Objectives: Assess the eligibility of outpatients with chronic heart failure for the trials DAPA-HF, EMPEROR-reduced, and PARADIGM-HF, while exploring potential differences among study populations.
Methods: By reviewing medical records, we determined the eligibility rate for each study and evaluated the incidence of heart failure hospitalizations and all-cause mortality during this period.
Cardiol Young
April 2024
Pediatric Cardiologist, CardioVid Clinic, Medellin, Colombia.
Background: The Fontan procedure is considered one of the most remarkable achievements in paediatric cardiology and cardiac surgery. Its final anatomical objective is a venous return through the superior and inferior vena cava. The complications inherent to this procedure and subsequent failure are its limitations.
View Article and Find Full Text PDFCurr Cardiol Rep
October 2023
Department of Cardiology, Mount Sinai Hospital, Icahn School of Medicine, New York, NY, USA.
Purpose Of Review: Describe disparities in diagnosis and management between men and women with advanced heart failure (HF). Our goal is to identify barriers and suggest solutions.
Recent Findings: Women with advanced HF are less likely to undergo diagnostic testing and procedures (i.
Eur J Heart Fail
October 2023
Heart Failure Department, Clinical Investigation Center, INSERM 1060 & 1407, Hospices Civils de Lyon, University Claude Bernard Lyon 1, Lyon, France.
JACC Heart Fail
September 2023
Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada. Electronic address:
Curr Probl Cardiol
December 2023
Department of Heart failure, Sanatorio Güemes, Buenos Aires, Argentina.
Endomyocardiofibrosis (EMF) is a restrictive cardiomyopathy characterized by subendocardial fibrosis due to eosinophilic myocardial infiltration. EMF may commonly present with heart failure (HF) or atrial fibrillation (AF). Immunosuppression can be effective in early stages, but not in the chronic phase.
View Article and Find Full Text PDFJ Clin Immunol
July 2023
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, 24 Boulevard du Montparnasse, Paris, France.
Background: Cryptococcosis is a potentially life-threatening fungal disease caused by encapsulated yeasts of the genus Cryptococcus, mostly C. neoformans or C. gattii.
View Article and Find Full Text PDFEur Heart J Suppl
December 2022
Institute of Heart Diseases, Cardiology Department, Medical University, Borowska 213, 50-556 Wroclaw, Poland.
Hospitalizations for heart failure (HF) have become a global problem worldwide. Each episode of HF decompensation may lead to deleterious short- and long- term consequences, but on the other hand is an unique opportunity to adjust the heart failure pharmacotherapy. Thus, in-hospital and an early post-discharge period comprise an optimal timing for initiation and optimization of the comprehensive management of HF.
View Article and Find Full Text PDFEur J Heart Fail
February 2023
Heart Failure Department and Clinical Investigation Center Inserm 1407, Louis Pradel Cardiovascular Hospital, Hospices Civils de Lyon, Claude Bernard University, Lyon, France.
Monaldi Arch Chest Dis
September 2022
Department of Cardiology Research, Torres de Salud National Research Center, Lima; Ingeniería Biomedica, Facultad de Ciencias y Filosofia, Universidad Peruana Cayetano Heredia, Lima; Departamento de Cardiologia, Hospital Nacional Edgardo Rebagliati Martins, Lima.
Red blood cell distribution width (RDW) has been shown to have prognostic value in a number of different clinical settings, such as cardiovascular disease, including heart failure. However, its prognostic value in heart transplant (HT) recipients remains unknown. The aim of this systematic review is to determine the prognostic value of pre-transplant RDW for mortality in HT recipients.
View Article and Find Full Text PDFEuropace
December 2022
C.H.U. du Sart-Tilman, Universite de Liege, Liege 4000, Belgium.
J Innov Card Rhythm Manag
March 2022
Cardiac Electrophysiology Unit, Monteprincipe University Hospital, Madrid, Spain.
The purpose of this study was to quantify the relationship between a drop in end-tidal carbon dioxide (etCO) and occlusion of pulmonary veins (PVs) to find a delta etCO (ΔetCO) able to predict occlusion during PV isolation (PVI) by cryoballoon. We designed a prospective registry. Paroxysmal atrial fibrillation patients who underwent cryoballoon PVI were included.
View Article and Find Full Text PDFEur J Heart Fail
May 2022
Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada.
Am J Trop Med Hyg
December 2020
3Pediatric Infectious Diseases, University of Antioquia, Cardiovid Clinic, Medellín, Colombia.
Rhinosporidiosis is caused by Rhinosporidium seeberi, a pathogen currently considered a fungus-like parasite of the eukaryotic group Mesomycetozoea. It is usually a benign condition, with slow growth of polypoid lesions, with involvement of the nose, nasopharynx, or eyes. The clinical characteristics of a painless, friable, polypoid mass, usually unilateral, can guide the diagnosis, but the gold standard for diagnosis is histopathological findings.
View Article and Find Full Text PDF